|
Volumn 20, Issue 26, 2001, Pages 3376-3386
|
Inhibition of cyclin A/CdK2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator
|
Author keywords
B Myb; CBP; Cyclin A; Phosphorylation; Transcriptional regulation
|
Indexed keywords
CYCLIN A;
CYCLIN DEPENDENT KINASE 2;
DNA;
TRANSCRIPTION FACTOR;
TRANSCRIPTION FACTOR B MYB;
TRANSCRIPTION FACTOR CBP;
TRANSCRIPTION FACTOR E2F;
UNCLASSIFIED DRUG;
ARTICLE;
AUTOREGULATION;
BINDING SITE;
CELL CYCLE;
CONTROLLED STUDY;
HUMAN;
HUMAN CELL;
OSTEOSARCOMA CELL;
PRIORITY JOURNAL;
PROTEIN DNA INTERACTION;
PROTEIN PHOSPHORYLATION;
TRANSACTIVATION;
TRANSCRIPTION REGULATION;
BONE NEOPLASMS;
CDC2-CDC28 KINASES;
CELL CYCLE PROTEINS;
CREB-BINDING PROTEIN;
CYCLIN A;
CYCLIN-DEPENDENT KINASE 2;
CYCLIN-DEPENDENT KINASES;
DNA;
DNA-BINDING PROTEINS;
GENE EXPRESSION REGULATION, NEOPLASTIC;
MODELS, GENETIC;
NEOPLASM PROTEINS;
NUCLEAR PROTEINS;
OSTEOSARCOMA;
PEPTIDE FRAGMENTS;
PHOSPHORYLATION;
PROTEIN BINDING;
PROTEIN PROCESSING, POST-TRANSLATIONAL;
PROTEIN STRUCTURE, TERTIARY;
PROTEIN-SERINE-THREONINE KINASES;
RECOMBINANT FUSION PROTEINS;
SEQUENCE DELETION;
TRANS-ACTIVATION (GENETICS);
TRANS-ACTIVATORS;
TRANSFECTION;
TUMOR CELLS, CULTURED;
|
EID: 0035821710
PISSN: 09509232
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.onc.1204439 Document Type: Article |
Times cited : (36)
|
References (53)
|